收藏切换
Progress on cardiovascular outcomes of glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes mellitus
收藏切换
Shuyun SHEN
World Clinical Drug | 2022, 43(9) : 1199 - 1206
Less
收藏切换
World Clinical Drug | 2022, 43(9): 1199-1206
• Review •
Progress on cardiovascular outcomes of glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes mellitus
Full
Shuyun SHEN
Affiliations
  • Qilu Pharmaceutical Co., Ltd., Jinan 250101, Shandong Province, China
Published: 2022-09-10 doi: 10.13683/j.wph.2022.09.020
Outline
收藏切换

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) is a new class of hypoglycemic drugs, which is increasingly important in the treatment of type 2 diabetes mellitus (T2DM) due to its outstanding effects of hypoglycemia, weight loss and low risk of hypoglycemia. Over the past several years, the developer has completed seven cardiovascular outcome trial (CVOT) involving liraglutide, once-weekly long-acting exenatide, lixisenatide, abirlutide, duraglutide, semaglutide as a subcutaneous injection, and semaglutide as an oral formulation. The cardiovascular outcomes of all GLP-1 RAs were found to be noninferior to placebo, and some GLP-1 RAs were found to be superior. The results of these trials have changed national guidelines for medical treatment of T2DM. This article reviewed 7 CVOTs of GLP-1 RAs, in order to provide more support for clinical medication.

glucagon-like peptide-1 receptor agonist  /  type 2 diabetes mellitus  /  cardiovascular disease  /  cardiovascular outcome trial
沈舒云. 胰高血糖素样肽-1受体激动剂对2型糖尿病患者的心血管结局. 世界临床药物, 2022 , 43 (9) : 1199 -1206 . DOI: 10.13683/j.wph.2022.09.020
Shuyun SHEN. Progress on cardiovascular outcomes of glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes mellitus[J]. World Clinical Drug, 2022 , 43 (9) : 1199 -1206 . DOI: 10.13683/j.wph.2022.09.020
Year 2022 volume 43 Issue 9
10
0
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.09.020
  • Receive Date:2022-03-14
  • Online Date:2026-11-19
  • Published:2022-09-10
Article Data
Affiliations
History
  • Received:2022-03-14
Affiliations
    Qilu Pharmaceutical Co., Ltd., Jinan 250101, Shandong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.09.020
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT